【K1 0111 交流专区】企文科技

icy97

Type	Announcement
Subject	OTHERS
Description	Medical Device Authority ("MDA") of Malaysia Grants Approval To K-One MediTech Sdn Bhd To Distribute Silicone Adhesive Tape Primarily Used For Wound Care Dressing
1. Introduction The Board of Directors of K-One Technology Berhad (“K-One Tech” or ‘Company” or “K-One Group”) wishes to announce that the Company’s wholly-owned subsidiary, K-One MediTech Sdn Bhd (“K-One MediTech”) has on 27 September 2022 received approval from the Medical Device Authority (“MDA”) under the Ministry of Health, Malaysia to distribute and sell silicone adhesive tapes primarily used for wound care dressing. The K-One Group will sell the silicone adhesive tapes in Malaysia as an authorized representative of Wuhan Huawei Technology Co., Ltd (“WH Tech”) which is the manufacturer based in China. 2. About WH Tech & K-One MediTech 2.1   WH Tech WH Tech, the developer and manufacturer of the silicone adhesive tapes is based in Wuhan, Hubei, China. It specializes in developing, manufacturing and marketing of various advanced wound dressings and other medical products. Since its establishment in 2002, WH Tech has been accorded with ISO 9001, ISO 13485, FDA and CE certifications. 2.2  K-One MediTech K-One MediTech is a wholly-owned subsidiary of K-One Tech. It was incorporated in 2001. Its principal business and focus are in the development, manufacturing and supply of medical and healthcare products which includes medical devices, healthcare consumables, oral care gadgets and hospital equipment. 3.  Silicone Adhesive Tapes For Wound Care Applications & MDA Approval The silicone adhesive tapes are advanced wound dressings which come in three product types. The first two product categories are applicable to a variety of indwelling catheters, electrodes or other external fixations that require gentle but robust skin protection and adhesion, while the third product type helps to improve scar appearance (including hypertrophic and keloid) and restores skin to a more natural color and texture. It also alleviates itchy skin and discomfort associated with scars. MDA has approved the distribution and sale of the above silicone adhesive tapes in three product categories for a period of five years from 26 September 2022 to 25 September 2027. The approval will provide the opportunity for the K-One Group to further expand its medical device business. The silicone adhesive tape wound dressing market is growing as its demand is anticipated to increase in tandem with the rising trend of surgeries performed in Malaysia (and abroad). Moreover, increasing awareness relating to the employment of medical tapes for securement among physicians and patients and the rising incidence of wounds, burns, injuries are anticipated to spice up the market demand. 4. Financial Effects The approval will have immaterial impact on the net assets and gearing of K-One Tech for the financial year ending 31 December 2022. It will not have any effect on the issued and paid-up share capital and the substantial shareholders’ shareholding in K-One Tech. With the distribution and marketing process anticipated to commence immediately and sales progressively scaling up in the coming years, it is expected to contribute positively to the earnings of K-One Tech for the financial years ending 31 December 2022 and beyond. 5. Risk Factors The import and distribution of the said silicone adhesive tapes will be subjected to various risks which include supply chain disruptions, pricing changes, market demand volatility, competition and currency rates fluctuation. Notwithstanding, the K-One Group has established a successful track record in undertaking manufacturing and distribution of medical devices which would help in mitigating such risks.   6. Approvals Required The distribution and sales of the said silicone adhesive tapes for wound care dressing do not require approval from the shareholders of K-One Tech or relevant authorities except MDA which it has received the necessary approval. 7. Directors’ Statement The Board of K-One Tech is of the opinion that the distribution and supply of the said silicone adhesive tapes primarily for wound care applications is in the best interest of the K-One Group after considering its potential and synergy to its existing healthcare business segment. This announcement is dated 28 September 2022.

icy97

Type	Announcement
Subject	OTHERS
Description	MEDICAL DEVICE AUTHORITY (MDA) OF MALAYSIA GRANTS REGISTRATION APPROVAL TO K-ONE MEDITECH SDN BHD TO DISTRIBUTE DIVERSEY'S DISINFECTANT WIPES USED FOR CLEANING SURFACES AND EQUIPMENT
The Board of Directors of K-One Technology Berhad (“K-One Tech” or ‘Company” or “K-One Group”) wishes to announce that the Company’s wholly-owned subsidiary, K-One MediTech Sdn Bhd (“K-One MediTech”) has on 30 August 2023 received approval from the Medical Device Authority (“MDA”) under the Ministry of Health, Malaysia for registration of Diversey’s Oxivir Excel disinfectant wipes (“wipes”) used for cleaning surfaces and equipment to be distributed in Malaysia. The K-One Group will sell the wipes in Malaysia as the exclusive distributor of Diversey (Malaysia) Sdn Bhd (“Diversey”).   Please refer to the attachment for details of the announcement. This announcement is dated 1 September 2023.

https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3382677

Attachments MDA approval of Wipes.pdf

icy97

Type	Announcement
Subject	OTHERS
Description	K-ONE TECHNOLOGY BERHAD ("K-ONE" OR THE "COMPANY")PROPOSED DIVERSIFICATION
On behalf of the Board of Directors of K-One ("Board"), UOB Kay Hian Securities (M) Sdn Bhd ("UOBKH") wishes to announce that the Company intends to undertake the proposed diversification of the existing business of K-One and its subsidiaries ("K-One Group" or the "Group") to include the distribution and sale of healthcare products ("Healthcare Products Business") ("Proposed Diversification"). Further details of the Proposed Diversification are set out in the attachment. This announcement is dated 1 April 2024.

https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3435433

Attachments K-One - Announcement.pdf

icy97

SUMMARY OF KEY FINANCIAL INFORMATION 30 Jun 2024

		INDIVIDUAL PERIOD		CUMULATIVE PERIOD
		CURRENT YEAR QUARTER	PRECEDING YEAR CORRESPONDING QUARTER	CURRENT YEAR TO DATE	PRECEDING YEAR CORRESPONDING PERIOD
		30 Jun 2024	30 Jun 2023	30 Jun 2024	30 Jun 2023
		$$'000	$$'000	$$'000	$$'000

1	Revenue	44,754	43,214	89,645	84,161
2	Profit/(loss) before tax	1,219	366	3,518	138
3	Profit/(loss) for the period	1,079	18	2,764	-407
4	Profit/(loss) attributable to ordinary equity holders of the parent	1,008	18	2,831	-407
5	Basic earnings/(loss) per share (Subunit)	0.12	0.00	0.34	-0.05
6	Proposed/Declared dividend per share (Subunit)	0.00	0.00	0.00	0.00
		AS AT END OF CURRENT QUARTER		AS AT PRECEDING FINANCIAL YEAR END
7	Net assets per share attributable to ordinary equity holders of the parent ($$)	0.1434		0.1400

icy97

Type	Announcement
Subject	TRANSACTIONS (CHAPTER 10 OF LISTING REQUIREMENTS) RELATED PARTY TRANSACTIONS
Description	K-ONE TECHNOLOGY BERHAD ("K-ONE" OR "COMPANY")- PURCHASE OF FACTORY FROM LIM BENG FOOK/LIM SOON SENG BY K-ONE MEDITECH SDN BHD, A WHOLLY-OWNED SUBSIDIARY OF K-ONE TECHNOLOGY BHD.
Pursuant to Rule 10.08(1) of the ACE Marketing Listing Requirements of Bursa Malaysia Securities Berhad, the Board of Directors of K-One Technology Bhd (“K-One” or “Company”) wishes to announce that its wholly-owned subsidiary, K-One MediTech Sdn. Bhd. (“K-One MediTech”) has on 4 October 2024 entered into a Sale and Purchase Agreement (“SPA”) with related parties, namely Lim Beng Fook and Lim Soon Seng for the purchase of a piece of leasehold land together with a one (1) unit of two (2) storey detached factory erected thereon bearing postal address 68, Lengkok Rishah 2, Kawasan Perindustrian Silibin, 30100 Ipoh, Perak for a total consideration of RM3,000,000.00 ("the Purchase"). The Purchase is a related party transaction as Lim Beng Fook and Lim Soon Seng who are the Executive Chairman and CEO of K-One respectively are the related parties and are interested in the Purchase. Please refer to the attachment for further details. This announcement is dated 4 October 2024.

https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3489310

Attachments K-One - RPT announcement.pdf

icy97

Type	Announcement
Subject	OTHERS
Description	K-ONE TECHNOLOGY BERHAD- MR GLOBAL (HK) LIMITED ("MINDRAY") APPOINTS K-ONE WELLNESS SDN BHD AS NON-EXCLUSIVE DISTRIBUTOR TO DISTRIBUTE ITS AUTOMATED EXTERNAL DEFIBRILLATORS (AEDS) IN MALAYSIA.
The Board of Directors of K-One Technology Berhad (“K-One Tech” or ‘Company” or “K-One Group”) wishes to announce that the Company’s wholly-owned subsidiary, K-One Wellness Sdn Bhd has entered into a Distribution and Supply Agreement with MR Global (HK) Limited (“Mindray”) to distribute on a non-exclusive basis the latter’s automated external defibrillators (“AEDs”) for the public (non-hospital) sector in Malaysia which was signed and noted on 12 February 2025. Please refer to the attachment for details. This announcement is dated 13 February 2025.

https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3523155

Attachments K-One - Announcement on Distribution of Healthcare.pdf

icy97

SUMMARY OF KEY FINANCIAL INFORMATION 31 Dec 2024

		INDIVIDUAL PERIOD		CUMULATIVE PERIOD
		CURRENT YEAR QUARTER	PRECEDING YEAR CORRESPONDING QUARTER	CURRENT YEAR TO DATE	PRECEDING YEAR CORRESPONDING PERIOD
		31 Dec 2024	31 Dec 2023	31 Dec 2024	31 Dec 2023
		MYR'000	MYR'000	MYR'000	MYR'000

1	Revenue	54,056	40,635	201,724	167,250
2	Profit/(loss) before tax	-934	1,772	1,872	148
3	Profit/(loss) for the period	-857	2,587	619	232
4	Profit/(loss) attributable to ordinary equity holders of the parent	-591	2,739	201	350
5	Basic earnings/(loss) per share (Subunit)	-0.07	0.33	0.02	0.04
6	Proposed/Declared dividend per share (Subunit)	0.00	0.00	0.00	0.00
		AS AT END OF CURRENT QUARTER		AS AT PRECEDING FINANCIAL YEAR END
7	Net assets per share attributable to ordinary equity holders of the parent	0.1401		0.1400

icy97

Type	Announcement
Subject	OTHERS
Description	K-ONE TECHNOLOGY BERHAD- CIGA HEALTHCARE LTD, UK APPOINTS K-ONE WELLNESS SDN BHD AS EXCLUSIVE DISTRIBUTOR TO DISTRIBUTE ITS FERTILITY AND OTHER PRODUCT RANGE OF HEALTHCARE TEST KITS UNDER THE "SURESIGN" BRAND IN MALAYSIA.
The Board of Directors of K-One Technology Berhad (“K-One Tech” or “Company” or “K-One Group”) wishes to announce that the Company’s wholly-owned subsidiary, K-One Wellness Sdn Bhd (“K-One Wellness”) has on 27 March 2025 entered into a Distribution Agreement with CIGA Healthcare Ltd based in United Kingdom to distribute the latter’s product range of fertility and other healthcare test kits in Malaysia. Please refer to the attachment for details. This announcement is dated 27 March 2025.

https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3539018

Attachments K-One - Announcement on Distribution of Healthcare.pdf

icy97

K-ONE TECHNOLOGY BERHAD

Date of change	02 May 2025
Name	MR CHOI KENG MUN
Age	56
Gender	Male
Nationality	Malaysia
Type of change	Resignation
Designation	Others
Reason	Internal reorganization of Finance and Accounts function of K-One Group.
Details of any disagreement that he/she has with the Board of Directors	No
Whether there are any matters that need to be brought to the attention of shareholders	No

Qualifications

No Qualifications Major/Field of Study Institute/University Additional Information

Remarks :

Mr Choi Keng Mun ceased as the Principal Officer of K-One Technology Berhad. However, he continues serving the K-One Group as Senior Finance Director, responsible for corporate finance and special functions. Ms Caris Lim Soh Choon, who is currently the Associate Finance Director, will replace him as the Principal Officer and head the Finance & Accounts function of the K-One Group.

Date of change	02 May 2025
Name	MISS LIM SOH CHOON
Age	43
Gender	Female
Nationality	Malaysia
Type of change	Appointment
Designation	Others

Qualifications

No Qualifications Major/Field of Study Institute/University Additional Information 1 Professional Qualification Accounting Association of Chartered Certified Accountants (ACCA) Member 2 Professional Qualification Accounting Malaysian Institute of Accountants (MIA) Member
Working experience and occupation	Ms Lim Soh Choon ("Ms Caris Lim") joined the K-One Group as Associate Finance Director in August 2024. Prior to that, she accumulated nearly 20 years of experience in audit, corporate governance, and financial management, having previously served with financial institutions and other private sector companies.
Directorships in public companies and listed issuers (if any)	NIL
Family relationship with any director and/or major shareholder of the listed issuer	NIL
Any conflict of interests that he/she has with the listed issuer	NIL
Details of any interest in the securities of the listed issuer or its subsidiaries	NIL

Remarks :

Ms Caris Lim holds the position of Associate Finance Director. She will be responsible for the K-One Group's operations finance which includes financial planning, accounts, budgeting, treasury, tax and other aspects of financial/accounts management.

icy97

SUMMARY OF KEY FINANCIAL INFORMATION 31 Mar 2025

		INDIVIDUAL PERIOD		CUMULATIVE PERIOD
		CURRENT YEAR QUARTER	PRECEDING YEAR CORRESPONDING QUARTER	CURRENT YEAR TO DATE	PRECEDING YEAR CORRESPONDING PERIOD
		31 Mar 2025	31 Mar 2024	31 Mar 2025	31 Mar 2024
		MYR'000	MYR'000	MYR'000	MYR'000

1	Revenue	58,466	44,891	58,466	44,891
2	Profit/(loss) before tax	969	2,299	969	2,299
3	Profit/(loss) for the period	685	1,685	685	1,685
4	Profit/(loss) attributable to ordinary equity holders of the parent	670	1,823	670	1,823
5	Basic earnings/(loss) per share (Subunit)	0.08	0.22	0.08	0.22
6	Proposed/Declared dividend per share (Subunit)	0.00	0.00	0.00	0.00
		AS AT END OF CURRENT QUARTER		AS AT PRECEDING FINANCIAL YEAR END
7	Net assets per share attributable to ordinary equity holders of the parent	0.1409		0.1401

icy97

Type	Announcement
Subject	OTHERS
Description	K-ONE TECHNOLOGY BERHAD- K-ONE WELLNESS SDN BHD TO COLLABORATE WITH MYRESQ SDN BHD AS ITS CARDIOPULMONARY RESUSCITATION (CPR) AND FIRST AID TRAINING PARTNER AND REPRESENTATIVE THROUGH A MEMORANDUM OF AGREEMENT (MOA).
The Board of Directors of K-One Technology Berhad (“K-One Tech” or “Company” or “K-One Group”) wishes to announce that the Company’s wholly-owned subsidiary, K-One Wellness Sdn Bhd (“K-One Wellness”) has on 7 August 2025 entered into a Memorandum of Agreement with MyResQ Sdn Bhd ("MyResQ"). This collaboration designates MyResQ as the official Cardiopulmonary Resuscitation (CPR) and First Aid Training Partner and Representative for K-One Wellness, with the purpose of enhancing CPR capabilities targeting the working population and promoting awareness and education in emergency medical response amongst the public. Please refer to the attachment for details. This announcement is dated 7 August 2025.

https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3578588

Attachments K-One - Announcement on Memorandum of Agreement.pdf

icy97

SUMMARY OF KEY FINANCIAL INFORMATION 30 Jun 2025

		INDIVIDUAL PERIOD		CUMULATIVE PERIOD
		CURRENT YEAR QUARTER	PRECEDING YEAR CORRESPONDING QUARTER	CURRENT YEAR TO DATE	PRECEDING YEAR CORRESPONDING PERIOD
		30 Jun 2025	30 Jun 2024	30 Jun 2025	30 Jun 2024
		MYR'000	MYR'000	MYR'000	MYR'000

1	Revenue	64,548	44,754	123,014	89,645
2	Profit/(loss) before tax	989	1,219	1,958	3,518
3	Profit/(loss) for the period	619	1,079	1,304	2,764
4	Profit/(loss) attributable to ordinary equity holders of the parent	320	1,008	990	2,831
5	Basic earnings/(loss) per share (Subunit)	0.04	0.12	0.12	0.34
6	Proposed/Declared dividend per share (Subunit)	0.00	0.00	0.00	0.00
		AS AT END OF CURRENT QUARTER		AS AT PRECEDING FINANCIAL YEAR END
7	Net assets per share attributable to ordinary equity holders of the parent	0.1414		0.1401